| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 9, 2023 | RLS Global and Convatec have agreed to terminate collaboration agreement | RLS Global and Convatec have agreed to terminate collaboration agreement
Thu, Nov 09, 2023 22:00 CET Report this content
RLS Global and Convatec have mutually agreed to terminate their collaboration agreement for ChloraSolv in European mark... |
| Nov 9, 2023 | RLS Global initiates strategic review process aiming to commercialize ChloraSolv | RLS Global initiates strategic review process aiming to commercialize ChloraSolv
Thu, Nov 09, 2023 22:15 CET Report this content
The RLS Global Board of Directors has resolved to initiate a strategic review process to enable the commercial ... |
| Sep 6, 2023 | First patient included in new clinical investigation on pressure ulcers | First patient included in new clinical investigation on pressure ulcers
Wed, Sep 06, 2023 09:00 CET Report this content
RLS Global’s new clinical investigation with ChloraSolv for the treatment of pressure ulcers includes six clinics in Swe... |
| Sep 1, 2023 | ChloraSolv recommended for UK CA certification required for UK market after Brexit | ChloraSolv recommended for UK CA certification required for UK market after Brexit
Fri, Sep 01, 2023 13:00 CET Report this content
As a result of Brexit, a so-called UK CA certification will be required for medical devices placed on the mar... |
| Aug 25, 2023 | RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL–JUNE 2023 | RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL–JUNE 2023
Fri, Aug 25, 2023 09:00 CET Report this content
RLS Global AB (publ) (“RLS”) or the “Company”) today publishes the Company’s interim report for the second quarter ... |
| Aug 24, 2023 | RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0 | RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0
Thu, Aug 24, 2023 18:30 CET Report this content
RLS Global AB (publ) (“RLS”) or the “Company”) has today, 24 August 2023, raised a short-term loan of MSEK 5.0 from a number of extern... |
| May 31, 2023 | RLS Global AB (publ) Interim Report, Q1, 2023 | RLS Global AB (publ) Interim Report, Q1, 2023
Wed, May 31, 2023 08:30 CET Report this content
JANUARY 1st – MARCH 31st (Previous year in brackets) Net sales amounted to TSEK 89 (TSEK 305) Earnings before interest and taxes (EBIT) amounted t... |
| Mar 20, 2023 | ChloraSolv shows notably greater antibiofilm activity in vitro compared to other debridement products in published article | ChloraSolv shows notably greater antibiofilm activity in vitro compared to other debridement products in published article
Mon, Mar 20, 2023 11:00 CET Report this content
A recently published article in Wounds UK concludes that ChloraSolv w... |
| Feb 28, 2023 | RLS Global AB (publ) Year-end Report, Q4, 2022 | RLS Global AB (publ) Year-end Report, Q4, 2022
Tue, Feb 28, 2023 08:30 CET Report this content
OCTOBER 1st – DECEMBER 31st (previous year in brackets) Net sales amounted to TSEK 291 (TSEK 219) Earnings before interest and taxes (EBIT) amoun... |
| Jan 24, 2023 | Lars Johansson nominated as new Chairman of the Board of RLS Global AB | Lars Johansson nominated as new Chairman of the Board of RLS Global AB
Tue, Jan 24, 2023 21:40 CET Report this content
RLS Global AB announces today that Lars Johansson is nominated for election as new Chairman of the Board. Current Chairma... |
| Dec 9, 2022 | RLS Global: The rights issue is registered and the trading in Paid Subscription Shares ceases | RLS Global: The rights issue is registered and the trading in Paid Subscription Shares ceases
Fri, Dec 09, 2022 09:00 CET Report this content
RLS Global AB (publ) (”RLS Global” or "the Company”) has completed a rights issue of shares t... |
| Nov 24, 2022 | RLS Global AB (publ) Interim Report, Q3, 2022 | RLS Global AB (publ) Interim Report, Q3, 2022
Thu, Nov 24, 2022 08:00 CET Report this content
JULY 1st – SEPTEMBER 30th (Previous year in brackets) Net sales amounted to TSEK 198 (TSEK 132). Earnings before interest and taxes (EBIT) amounte... |
| Nov 14, 2022 | RLS Global: Outcome in RLS Global’s rights issue | RLS Global: Outcome in RLS Global’s rights issue
Mon, Nov 14, 2022 22:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO RUSSIA, BELARUS, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEAL... |
| Nov 10, 2022 | Presentation by Björn Larsson, CEO, RLS Global AB, about the company’s operations and the currently ongoing rights issue | Presentation by Björn Larsson, CEO, RLS Global AB, about the company’s operations and the currently ongoing rights issue
Thu, Nov 10, 2022 11:00 CET Report this content
Meet Björn Larsson, CEO of RLS Global AB, when he presents the company ... |
| Nov 4, 2022 | RLS Global’s CEO Björn Larsson interviewed by Erik Penser Bank about the ongoing rights issue | RLS Global’s CEO Björn Larsson interviewed by Erik Penser Bank about the ongoing rights issue
Fri, Nov 04, 2022 14:30 CET Report this content
Erik Penser Bank has today published a video-recorded interview with Björn Larsson, CEO, RLS Globa... |
| Aug 26, 2022 | RLS GLOBAL AB (PUBL) INTERIM REPORT, Q2, 2022 | RLS GLOBAL AB (PUBL) INTERIM REPORT, Q2, 2022
Fri, Aug 26, 2022 09:00 CET Report this content
APRIL 1st – JUNE 30th (Previous year in brackets) Net sales amounted to TSEK 397 (TSEK 244). Earnings before interest and taxes (EBIT) amounted to... |
| Aug 23, 2022 | Björn Larsson new CEO of RLS Global | Björn Larsson new CEO of RLS Global
Tue, Aug 23, 2022 09:00 CET Report this content
The Board of Directors of RLS Global AB (publ) has today appointed Björn Larsson as new CEO. Björn Larsson, who joins the company from Observe Medical ASA, ... |
| Aug 11, 2022 | New case reports of ChloraSolv presented in Journal of Wound Care supplement | New case reports of ChloraSolv presented in Journal of Wound Care supplement
Thu, Aug 11, 2022 09:00 CET Report this content
During the last six months, RLS Global and ConvaTec have worked in close collaboration to collect clinical experien... |
| Jul 13, 2022 | ChloraSolv is available in the UK through NHS Supply Chain | ChloraSolv is available in the UK through NHS Supply Chain
Wed, Jul 13, 2022 08:30 CET Report this content
As of 11th of July 2022, ChloraSolv is available in the UK to NHS (National Health Service) organizations who purchase from NHS Suppl... |
| Jun 1, 2022 | RLS Global introduces ChloraSolv in the veterinary care segment in Scandinavia | RLS Global introduces ChloraSolv in the veterinary care segment in Scandinavia
Wed, Jun 01, 2022 08:30 CET Report this content
RLS Global’s strategic focus is to expand its technical platform, buffered hypochlorite technology, to new indica... |
| May 30, 2022 | RLS Global increases its presence in the Middle East | RLS Global increases its presence in the Middle East
Mon, May 30, 2022 08:30 CET Report this content
RLS Global strengthens its presence in the Middle East. Through a regional agent, Med Surg, the company will establish a local distribution... |
| May 11, 2022 | RLS GLOBAL AB (publ) INTERIM REPORT, Q1, 2022 | RLS GLOBAL AB (publ) INTERIM REPORT, Q1, 2022
Wed, May 11, 2022 09:00 CET Report this content
JAN 1st – MARCH 31st (Previous year in brackets)
Net sales amounted to TSEK 305 (TSEK 50).
Earnings before interest and taxes (EBIT) amounted to T... |
| Apr 4, 2022 | RLS Global announces management change | RLS Global announces management change
Mon, Apr 04, 2022 08:55 CET Report this content
Karin Fischer has given notice that she intends to resign as CEO of RLS Global AB (publ). The Board has initiated the search for a new, R&D-focused C... |
| Feb 25, 2022 | RLS GLOBAL AB (publ) YEAR-END REPORT, Q4, 2021 | RLS GLOBAL AB (publ) YEAR-END REPORT, Q4, 2021
Fri, Feb 25, 2022 09:00 CET Report this content
OCTOBER 1st – DECEMBER 31st (previous year in brackets)
Net sales amounted to TSEK 219 (TSEK 139)
Earnings before interest and taxes (EBIT) amoun... |
| Jan 12, 2022 | Further progress with ChloraSolv[®] roll out across Europe – market access activities in the Netherlands signal positive momentum | Further progress with ChloraSolv[®] roll out across Europe – market access activities in the Netherlands signal positive momentum Wed, Jan 12, 2022 08:00 CET
RLS Global, a medical healthcare company based in Sweden, and ConvaTec, one of the... |
| Nov 19, 2021 | RLS Global AB secures financing of SEK 20 million | RLS Global AB secures financing of SEK 20 million Fri, Nov 19, 2021 08:30 CET
RLS Global has today signed a credit facility, on market terms, of SEK 20 million to create flexible financing for the company’s continued growth. It is one of th... |
| Nov 12, 2021 | RLS Global AB (publ) Interim Report, Q3, 2021 | RLS Global AB (publ) Interim Report, Q3, 2021 Fri, Nov 12, 2021 14:00 CET
JULY 1st – SEPTEMBER 3Oth Net sales amounted to TSEK 132 (TSEK 793) Earnings before interest and taxes (EBIT) amounted to MSEK -6,2 (MSEK -5,6) Earning per share befo... |
| Jul 16, 2021 | RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2021 | RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2021 Fri, Jul 16, 2021 09:00 CET
APRIL 1st – JUNE 3Oth
Net sales amounted to TSEK 244 (TSEK 739)
Earnings before interest and taxes (EBIT) amounted to MSEK 8,5 (MSEK -5,6)
Other income TSEK 15 429 (T... |
| May 7, 2021 | RLS GLOBAL AB (PUBL)
RLS GLOBAL () : INTERIM REPORT, Q1, 2021 | JAN 1st - MARCH 31st Net sales amounted to KSEK 50 (KSEK 374) Earnings before interest and taxes (EBIT) amounted to MSEK -6,3 (MSEK -3,9) Earning per share before dilution at SEK -0,09 (SEK-0,06) Cash flow from operating activities amounted... |
